GLP-1 Agonists

• 12/23/2024

  Merck Bets Big on Obesity Market with $2 Billion Weight Loss Pill Deal

• 12/8/2024

  Zepbound vs Wegovy: New Obesity Treatment Wins in Head-to-Head Trial

• 12/7/2024

  Pharma’s New Guard: Why Vertex and Viking Are Leaving Pfizer Behind

• 10/23/2024

  Pfizer’s Potential Turnaround: Why Billionaires Are Betting Big

• 10/20/2024

  Buy Alert: Eli Lilly’s Undervalued Stock Poised for Massive Growth

• 10/9/2024

  **Billionaire Buys 7.9 Million Shares of Beaten-Down Pharma Stock**